Literature DB >> 24446810

Delivery of polysaccharides using polymer particles: implications on size-dependent immunogenicity, opsonophagocytosis, and protective immunity.

Chakkumkal Anish1, Naeem Khan, Arun Kumar Upadhyay, Devinder Sehgal, Amulya Kumar Panda.   

Abstract

Bacterial capsular polysaccharides are components of many modern vaccines, but they are weakly immunogenic. Herein, we describe the delivery of pneumococcal capsular polysaccharide serotype-1 (PCP-1) in polylactide polymeric particles to enhance its immunogenicity. Immunization with PCP-1-entrapped particles elicited long-term memory antibody responses from a single intramuscular injection. PCP-1-entrapped nanoparticles (NPs) elicited significantly higher anti-PCP-1 IgG responses than that observed with soluble and microparticles (MPs) formulations. Delivering PCP-1 and pneumococcal proteins in same particles did not improve the IgG response. The sera of animals immunized with PCP-1-entrapped particles promoted efficient opsonophagocytosis of pneumococci by macrophages. Single-dose immunization with PCP-1-entrapped particles conferred a long-term serotype-specific protection against lethal pneumococcal challenge. The higher immunogenicity of PCP-1 nanoparticles showed correlation with enhanced uptake by antigen-presenting cells. The results highlight the potential of polymeric nanoparticles as an efficient means of presenting polysaccharide antigens to the immune system.

Entities:  

Keywords:  antigen-delivery systems; memory antibody; opsonophagocytic assay; pneumococcal capsular polysaccharides; pneumococcal surface antigen A (PsaA); pneumococcal surface protein A (PspA); polylactide nanoparticles

Mesh:

Substances:

Year:  2014        PMID: 24446810     DOI: 10.1021/mp400589q

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  4 in total

Review 1.  Beyond antigens and adjuvants: formulating future vaccines.

Authors:  Tyson J Moyer; Andrew C Zmolek; Darrell J Irvine
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

Review 2.  Engineering nanoparticles to overcome barriers to immunotherapy.

Authors:  Randall Toy; Krishnendu Roy
Journal:  Bioeng Transl Med       Date:  2016-06-20

Review 3.  The Landscape of Nanovectors for Modulation in Cancer Immunotherapy.

Authors:  Simona-Ruxandra Volovat; Corina Lupascu Ursulescu; Liliana Gheorghe Moisii; Constantin Volovat; Diana Boboc; Dragos Scripcariu; Florin Amurariti; Cipriana Stefanescu; Cati Raluca Stolniceanu; Maricel Agop; Cristian Lungulescu; Cristian Constantin Volovat
Journal:  Pharmaceutics       Date:  2022-02-11       Impact factor: 6.321

Review 4.  Glyconanoparticles as tools to prevent antimicrobial resistance.

Authors:  Laura Morelli; Laura Polito; Barbara Richichi; Federica Compostella
Journal:  Glycoconj J       Date:  2021-03-17       Impact factor: 2.916

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.